The use of recombinant activated factor VII in platelet disorders: A critical review of the literature

Blood Transfusion

Volumn 7, Issue 1, 2009, Pages 24-28

  Franchini, Massimo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; CLOPIDOGREL; FIBRIN GLUE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

AUTOSOMAL RECESSIVE INHERITANCE; BERNAND SOULIER SYNDROME; BLEEDING; BLEEDING DISORDER; BLEEDING TIME; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DRUG EFFICACY; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; GLANZMANN DISEASE; HEMATOMA; HEMOPTYSIS; HLA SYSTEM; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LUNG EMBOLISM; PERIORBITAL HEMATOMA; RECOMMENDED DRUG DOSE; REVIEW; STORAGE POOL DISEASE; SUBDURAL HEMATOMA; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; THROMBOSIS; URETER DISEASE; URETER THROMBOSIS; VON WILLEBRAND DISEASE;

BLOOD PLATELET DISORDERS; FACTOR VIIA; HUMANS; RECOMBINANT PROTEINS;

EID: 65449118850     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2008.0015-08     Document Type: Review

References (40)

1. Jurlander B, Thim L, Klausen NK, et al. Recombinant activated factor VII (rFVIIa): characterization, manufacturing and clinical development. Semin Thromb Hemost 2001; 27: 373-383 (Pubitemid 32802893)
2. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002; 42: 114-124
3. Uhlmann EJ, Eby CS. Recombinant activated factor VIII for non-hemophiliac bleeding patients. Curr Opin Hematol 2004; 11: 198-204. (Pubitemid 38952010)
4. Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 2005; 93: 1027-1035
5. Kessler CM. New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate. Curr Opin Hematol 2000; 7: 408-413
6. Ghorashian S, Hunt BJ. "Off-license" use of recombinant activated factor VII. Blood Rev 2004;18:245-259.
7. Mathew P. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. Thromb Haemost 2004; 92: 738-746
8. Lisman T, De Groot PG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003; 1: 1138-1139
9. Laurian Y. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 2002; 32: 37-40.
10. Nurden AT. Inherited abnormalities of platelets. Thromb Haemost 1999; 82: 468-480
11. Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996; 75: 981-982 (Pubitemid 26355365)
12. Chuansumrit A, Sangkapreecha C, Hathirat P. Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa. Thromb Haemost 1999; 82: 1778.
13. Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94: 3951-3953
14. Poon MC, d'Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000; 11(Suppl 1): S55-68.
15. Poon MC, d'Oiron R, Hann I, et al. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001; 38: 21-25
16. Poon MC, D'Oiron R, Von Depka M, et al; International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2004; 2: 1096-1103
17. Caglar K, Cetinkaya A, Aytac S, et al. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatr Hematol Oncol 2003; 20: 435-438 (Pubitemid 37039930)
18. Chuansumrit A. Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia. J Thromb Haemost 2003; 1: 396.
19. Chuansumrit A, Suwannuraks M, Sri-Udomporn N, et al. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagul Fibrinolysis 2003; 14: 187-190 (Pubitemid 36332482)
20. Almeida A, Khair K, Hann I, Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003; 121: 477-481 (Pubitemid 36628341)
21. d'Oiron R, Menart C, Trzeciak MC, et al. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000; 83: 644-647
22. Valentino LA. Use of rFVIIa in 4 children with Glanzmann thromboasthenia. J Pediatr Hematol Oncol 2004; 28: 653-658
23. Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 1998; 80: 352. (Pubitemid 28393644)
24. Fressinaud E, Sigaud-Fiks M, Le Boterff C, Piot B. Use of recombinant factor VIIa (NovoSeven®) for dental extraction in a patient affected by platelet-type (pseudo) von Willebrand disease. Haemophilia 1998;4:XXIIIth Congress of the World Federation of Hemophilia (abstract).
25. Poon MC. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa? Curr Hematol Rep 2003; 2: 139-147
26. Goodnough LT. Experiences with recombinant human factor VIIa in patients with thrombocytopenia. Semin Hematol 2004; 41(suppl 1): 25-29 (Pubitemid 38182712)
27. Culic S. Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. Br J Haematol 2003; 120: 909-910 (Pubitemid 36315119)
28. Wrobel G, Dobaczewski G, Patkowski D, et al. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia. Pediatr Blood Cancer 2006; 47: 729-730 (Pubitemid 44360043)
29. Kristensen J, Killander A, Hippe E, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26(suppl 1): 159-164 (Pubitemid 26075728)
30. Blatt J, Gold SH, Wiley JM, et al. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant 2001; 28: 405-407 (Pubitemid 32834361)
31. de Fabritiis P, Dentamaro T, Picardi A, et al. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies. Haematologica 2004; 89: 243-245 (Pubitemid 38796504)
32. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002; 30: 975-978 (Pubitemid 36097490)
33. Vidarsson B, Onundarson PT. Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 2000; 83: 634-635 (Pubitemid 30201148)
34. Gerotziafas GT, Zervas C, Gavrielidis G, et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematol 2002; 69: 219-222 (Pubitemid 34177478)
35. Brenner B, Hoffman R, Balashov D, et al. Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII. Clin Appl Thromb Hemost 2005; 11: 401-410 (Pubitemid 41546766)
36. Mantzios G, Tsirigotis P, Pappa V, et al. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding. Eur J Haematol 2007; 78: 173-174 (Pubitemid 46058884)
37. Savani BN, Dunbar CE, Rick ME. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization. Am J Hematol 2006; 81: 218-219 (Pubitemid 43297269)
38. Revesz T, Arets B, Bierings M, et al. Recombinant factor VIIa in severe uremic bleeding. Thromb Haemost 1998: 80: 353. (Pubitemid 28393645)
39. Moisescu E, Ardelean L, Simion I, et al. Recombinant factor VIIa treatment of bleeding associated with acute renal failure. Blood Coagul Fibrinolysis 2000; 11: 575-577
40. Stepinska J, Banaszewski M, Konopka A, Szajewski T. Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban. Thromb Haemost 2002; 87: 355-356 (Pubitemid 34139886)